Thoma Bravo announced the completion of its strategic growth investment in Circle Cardiovascular Imaging Inc.(Circle CVI), the global leader in cardiovascular imaging solutions.
Circle CVI is the leading provider of AI-based cardiac imaging and reporting solutions, including cardiac MRI and cardiac CT imaging post-processing software. The company has developed a deep portfolio of specialized, accurate and intuitive solutions that are an integral part of precision medicine and enable physicians to deliver the highest quality care to their patients. Circle CVI’s solutions are used by thousands of clinical users, at both hospitals and academic institutions, in more than 50 countries. Thoma Bravo’s investment will bring significant operational and financial resources to allow the company to grow its leadership in the global cardiac imaging industry.
“With the close of this transaction, we’re excited to work with the Thoma Bravo team to accelerate our growth, drive continued product innovation and further solidify Circle CVI as the market leader,” said Greg Ogrodnick, CEO and Co-Founder of Circle CVI. “Together, we can continue building even better solutions and products to serve cardiovascular professionals and their patients across the world.”
“Circle CVI is the category leader in cardiac image post-processing solutions, and through our partnership we can help continue the company’s momentum and advance its product offerings while unlocking new global growth opportunities,” said Carl Press, a Partner at Thoma Bravo. “We are thrilled to work with Greg and the entire Circle CVI team and look forward to helping the company reach even greater heights.”
AGC Partners served as financial advisor to Circle CVI and Osler, Hoskin & Harcourt LLP served as legal counsel. Kirkland & Ellis, LLP and McMillan LLP served as legal counsel to Thoma Bravo. Deutsche Bank Credit Solutions and Direct Lending provided committed financing for the transaction.